MDSCs navigate the tumor microenvironment through chemokine receptors 2 (CCR2); GBM tumors express two CCR2 ligands, CCL2 and CCL7, which cause the tumor to signal the infiltration of CCR2+ cells (118). Here, CCL2 is linked to glioblastoma.